Isabelle Barber is Appointed to Exonhit Management Board
Exonhit announces the appointment of Isabelle Barber, Executive Vice-President, Diagnostics Division, as a member of its Management Board. This decision taken by the Supervisory Board of July 28th 2011 was effective immediately.
Isabelle, with 17 years of international experience in healthcare and biotech, 11 of which in the diagnostics industry, joined Exonhit in September 2010 as Senior Vice-President, Global Marketing for the Diagnostics Division. Currently Executive Vice-President, Diagnostics Division, Isabelle is in charge of the entire diagnostics activity: from strategy to R&D and commercialization.
Isabelle Barber, 43, started her career as a biomolecular chemist: first, as a R&D Senior Scientist at Isis Pharmaceuticals then as a Director of Chemistry at Genset. From July 1999 to August 2010, she worked on both side of the Atlantic for Ortho Clinical Diagnostics, a Johnson & Johnson company, where she held roles of increasing responsibilities in a variety of functions spanning from Customer Support and Training, Quality, Strategic Planning, Market Access and Development, to Global Marketing for the entire Clinical Laboratory portfolio of tests and reagents, a line of business representing more than one billion USD in annual sales.
Isabelle holds a Ph.D in Biomolecular Chemistry from the University of Montpellier, and an MBA from lAE (Business Administration Institute) in Strasbourg, France.
Exonhit Management Board is led by Loïc Maurel. Other members are Hervé Duchesne de Lamotte, CFO, and Matthew Pando, Executive Vice-President Therapeutics Division.
Other news from the department people
